This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Monday's Health Winners & Losers

Shares of Adeza Biomedical (ADZA) were among health care stocks' winners Monday, rising more than 50% on news of a merger.

Cytyc (CYTC) agreed to acquire the maker of products for women's health for $24 a share, or $452 million. The merger is expected to close by the end of March. Shares of Adeza were up $8.25, or 53%, to $23.78 in recent trading. Cytyc shares were up 59 cents, or 2%, at $30.14.

Onyx Pharmaceuticals (ONXX) was surging 91% Monday after the company said a trial of the liver cancer drug Nexavar met its primary endpoint. Onyx and partner Bayer (BAY) ended the phase III trial early on recommendation of an independent data-monitoring committee and gave all patients in the study access to Nexavar. Onyx shares were up $11.14 at $23.40 in recent trading.

Bristol-Myers Squibb (BMY) dropped lower on reports that merger talks with Sanofi-Aventis (SNY) have come to an end. Bristol shares were recently down $1.05, or 3.7%, at $27.47, while Sanofi was higher by 24 cents, or 0.6%, at $44.02.

Medifast (MED) climbed higher on an 83% year-over-year increase in full-year revenue. The weight-loss company reported unaudited revenue of $73.5 million, up from $40.1 million in 2005 and higher than its previous guidance of $70 million to $72 million. Analysts are looking for $73.3 million in revenue, according to Thomson First Call. Shares were recently higher by $1.37, or 17.6%, at $9.14.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,915.07 -70.54 -0.42%
S&P 500 1,964.68 -8.15 -0.41%
NASDAQ 4,396.2040 -22.83 -0.52%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs